BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 17488142)

  • 1. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled steroids for bronchiectasis.
    Kapur N; Bell S; Kolbe J; Chang AB
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000996. PubMed ID: 19160186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antiinflammatory therapy and macrolides in bronchiectasis.
    Feldman C
    Clin Chest Med; 2012 Jun; 33(2):371-80. PubMed ID: 22640852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA
    Rev Alerg Mex; 2006; 53(3):108-22. PubMed ID: 16970113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
    Majima Y
    Am J Med; 2004 Nov; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P; Papanas N; Kioumis I; Chatzaki E; Maltezos E; Zarogoulidis K
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cystic fibrosis bronchiectasis.
    McShane PJ; Naureckas ET; Tino G; Strek ME
    Am J Respir Crit Care Med; 2013 Sep; 188(6):647-56. PubMed ID: 23898922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
    Ilowite J; Spiegler P; Kessler H
    Drugs; 2009; 69(4):407-19. PubMed ID: 19323585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
    Haworth CS; Bilton D; Elborn JS
    Respir Med; 2014 Oct; 108(10):1397-408. PubMed ID: 25301290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New and Current Concepts of Therapy in Non-CF Bronchiectasis].
    Allewelt M; de Roux A
    Dtsch Med Wochenschr; 2016 May; 141(10):694-9. PubMed ID: 27176062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.
    Henkle E; Curtis JR; Chen L; Chan B; Aksamit TR; Daley CL; Griffith DE; Winthrop KL
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31000676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of macrolides in childhood lung diseases.
    Luisi F; Gandolfi TD; Daudt AD; Sanvitto JP; Pitrez PM; Pinto LA
    J Bras Pneumol; 2012; 38(6):786-96. PubMed ID: 23288126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
    Paredes Aller S; Quittner AL; Salathe MA; Schmid A
    Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.